KENALOG-H Drug Patent Profile
✉ Email this page to a colleague
When do Kenalog-h patents expire, and what generic alternatives are available?
Kenalog-h is a drug marketed by Delcor Asset Corp and is included in one NDA.
The generic ingredient in KENALOG-H is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kenalog-h
A generic version of KENALOG-H was approved as triamcinolone acetonide by TARO on October 1st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KENALOG-H?
- What are the global sales for KENALOG-H?
- What is Average Wholesale Price for KENALOG-H?
Summary for KENALOG-H
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 78 |
Patent Applications: | 4,322 |
DailyMed Link: | KENALOG-H at DailyMed |
Recent Clinical Trials for KENALOG-H
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Foundation for Orthopaedic Research and Education | Phase 1 |
Florida Orthopaedic Institute | Phase 1 |
Next Generation Regenerative Medicine LLC | Phase 1/Phase 2 |
US Patents and Regulatory Information for KENALOG-H
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delcor Asset Corp | KENALOG-H | triamcinolone acetonide | CREAM;TOPICAL | 086240-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KENALOG-H
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Delcor Asset Corp | KENALOG-H | triamcinolone acetonide | CREAM;TOPICAL | 086240-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for KENALOG-H
See the table below for patents covering KENALOG-H around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 507804 | ⤷ Sign Up | |
United Kingdom | 1578072 | ⤷ Sign Up | |
Canada | 1085725 | STEROIDE POUR APPLICATIONS LOCALES (TOPICAL STEROID FORMULATIONS) | ⤷ Sign Up |
Australia | 2236677 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |